BioMed Research International
Volume 2018 (2018), Article ID 4606791, 11 pages
https://doi.org/10.1155/2018/4606791

Research Article

Microbubble-Mediated Ultrasound Outweighs Low-Intensity Pulsed Ultrasound on Osteogenesis and Neovascularization in a Rabbit Model of Steroid-Associated Osteonecrosis

Dan-Feng Xu,1,2 Guo-Xin Qu,¹ Shi-Gui Yan,¹ and Xun-Zi Cai¹

¹Department of Orthopaedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Jie-fang Road 88, Hangzhou, 310009, China
²Department of Orthopaedic Surgery, Shaoxing Central Hospital, Hua-yu Road 1, Keqiao, Shaoxing, 312030, China

Correspondence should be addressed to Xun-Zi Cai; 2506053@zju.edu.cn

Received 17 May 2018; Revised 4 July 2018; Accepted 30 July 2018; Published 12 September 2018

Academic Editor: Naoaki Sakata

Copyright © 2018 Dan-Feng Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Microbubbles magnify the acoustic pressure of low-intensity pulsed ultrasound (LIPUS) and may enhance its bioeffect for diagnostic and therapeutic purposes. This study compared the effect of this novel microbubble-mediated ultrasound (MUS) with that of the traditional LIPUS on osteogenesis and neovascularization in a rabbit model of steroid-associated osteonecrosis. We hypothesized that MUS might outweigh LIPUS on promoting osteogenesis and neovascularization in steroid-associated osteonecrosis. The bilateral femoral head necrosis was induced by lipopolysaccharide and methylprednisolone in the rabbits. The indices of bone mineral density (BMD), trabecular number, maximal loading strength, and mineral apposition rate were analyzed, demonstrating that the animal model of steroid-associated osteonecrosis was successfully established. Both the MUS group () and the LIPUS group () were insonated 20 min daily for six weeks. received an extra intracapsular injection of microbubbles before insonation every other day. Fluorescence bone labeling, Micro-CT Analysis, biomechanical test, quantitative real-time PCR, Western blot analysis, and histological evaluation were performed for comparing with . The results demonstrated a 39% higher mineral apposition rate in compared with . The BMD and the maximal loading strength of femoral head of increased by 4.3% and 27.8% compared to those of , respectively. The mRNA and protein expression of BMP-2 and VEGF were also significantly higher in . The number of blood vessels of was 65% greater than that of . MUS is more potent than LIPUS in enhancing osteogenesis, neovascularization, and biomechanical strength of femoral head in the animal model of steroid-associated osteonecrosis. Without increasing the intensity of insonation or the risk of tissue damage, MUS is better for inhibiting the process of steroid-associated osteonecrosis.

1. Introduction

Steroid usage is the most common nontraumatic cause of osteonecrosis [1]. Up to 40% of steroid users will develop some degree of osteonecrosis, known as the steroid-associated osteonecrosis [2, 3]. The precise mechanism in which corticosteroids induce osteonecrosis is currently unclear. Hypotheses include fat cell hypertrophy, fat embolization, intravascular coagulation, and osteocyte apoptosis [4–6]. To our knowledge there is no established preventative method for steroid-associated osteonecrosis.

Low intensity pulsed ultrasound (LIPUS) is understood as a noninvasive, feasible, and economic modality for the delayed union and the nonunion of bone fractures. It is approved by the Food and Drug Administration in 1994. Since then, the research exploring the prospects of its clinical application has not stopped. The therapeutic application of LIPUS is worldwide nowadays. Recently, our team for the first time reported the effect of LIPUS on steroid-associated osteonecrosis in a rabbit model of steroid-associated osteonecrosis [7]. The authors revealed that LIPUS could promote the bone repair and the vascularization in vivo [7, 8]. It provides us a new insight to preventing the progression of steroid-associated osteonecrosis.

Microbubbles have been increasingly used to improve the therapeutic effect of LIPUS [9]. Microbubbles, with a gas-filled structure, are stabilized by a protein, lipid, or polymer shell. Microbubbles are initially developed as contrast agents for ultrasound imaging [10, 11]. They have the ability to produce mechanical actuations and shockwaves when they interact with the focal zone of LIPUS. More and more therapeutic applications of microbubbles are emerging at present [9, 12–14]. This novel ultrasound, known as microbubble-mediated ultrasound (MUS), has the ability to produce greater microstream and microjet than LIPUS [15, 16]. To our knowledge, whether MUS has more effect on the repair progress in steroid-associated osteonecrosis is unknown.

We hypothesized that MUS might outweigh the repair process of femoral head in steroid-associated osteonecrosis more efficiently than LIPUS. This study aimed to explore the enhancive effect of MUS on bone microstructure, mechanical strength, and vascularization compared with LIPUS

2. Methods and Materials

2.1. Experimental Design

The experimental protocol was approved by the Animal Care and Use Committee of Zhejiang University. Twenty-four adult male New Zealand rabbits (mean weight: 2.69 kg, range 2.45 to 3.00 kg) were used. The rabbit model of steroid-associated osteonecrosis was prepared using a protocol similar to the previous studies [17, 18]. To begin with, all the rabbits received intravenous injections of 10 μg/kg body weight of lipopolysaccharide (Escherichia coli 0111:B4; Sigma, St Louis, MO, USA). After 24 hours three injections of methylprednisolone (Pharmacia and Upjohn, Puurs, Belgium) (20 mg/kg body weight) were given intramuscularly every 24 hours. It has been reported that the osteonecrosis lesions began after two weeks and completed after six weeks [17]. The rabbits were randomly divided into three groups: the control group (), the LIPUS group (), and the MUS group ()(n = 8). Both and received LIPUS. Additionally received a 0.1 ml intracapsular injection (guided by B-ultrasound) of sulfur hexafluoride-filled microbubble solution (volume concentration: 7-8 μl/ ml, mean diameter: 2.5 mm, 90%, 6.0 mm, 99%, and 11.0 mm; Sonovue, Bracco, Geneva, Switzerland) before insonation [9] (Figure 1). Three rabbits were randomly selected for MRI (T1-weighted image, TR 400 ms, TE 20 ms; T2-weighted image, TR 2000 ms, and TE 106 ms) two weeks after methylprednisolone injection to test whether osteonecrosis was induced.

Figure 1: The flowchart of the study design (reproduced from Zhu et al. (2015), under the Creative Commons Attribution License/public domain). NZW = New Zealand White rabbits; ON = osteonecrosis; LPS = Lipopolysaccharide; MPS = methylprednisolone; = the control group; GL = the LIPUS group; GM = the MUS group; sp. = specimen.

2.2. Insonation

LIPUS (US 13; Cosmogamma Co, Bologna, Italy) was used at a pulse frequency of 1.0 MHz, an output intensity of 200 mW/cm², a 20% duty cycle, and a 100-Hz repetition rate [7]. Microbubble solution was prepared according to the manufacturer’s instructions. The skin around the hip was cleaned and ultrasound gel (KL-250; Keppler Co, Hangzhou, China) was used to couple the LIPUS transmission. The rabbits were anesthetized with 3% pentobarbital sodium before insonation. LIPUS therapy was administered to the bilateral femoral head 24 hours after the lipopolysaccharide injection and before the first methylprednisolone injection. The sham insonation was administered to the rabbits of (the device was turned off). In this study, rabbits were insonated with 20 minutes per day for six weeks. Then all the rabbits were euthanized with an overdose intravenous injection of pentobarbital sodium. Bilateral femurs of the hind leg were collected for analyses.

2.3. Fluorescence Bone Labeling

All the rabbits received intramuscular injections of a fluorescence tracer, alizarin complexone (30 mg/kg, Merck, Darmstadt, Germany), and calcein (10 mg/kg, Sigma, St. Louis, MO, USA) at 14 and 4 days, respectively, before the euthanasia to label newly mineralized bone. The mineral apposition rate (μm/day) (MAR = mean vertical distance between two fluorescence bands/injection interval), which generally indicated the mineralization rate of the newly formed bone, was analyzed [19].

2.4. Micro-CT Analysis

The proximal parts of the bilateral femur were prepared for micro-CT (eXplore Locus SP; GE Co, Fairfield, CT, USA) scanning, with a spatial resolution of 45 μm according to the protocol for animal studies. To evaluate the degree of plate-like and rod-like trabecular bone in the femoral head, a predetermined bone cylinder was used as the region of interest (3.0 mm diameter and 1.5 mm height) (Figure 4(d)) to quantify the mean volumetric bone mineral density (BMD) (mg/cc) and the trabecular architectural parameters, including the bone tissue volume density (bone volume/total volume, %), the trabecular number (/mm), the trabecular thickness (μm), the trabecular spacing (μm), and the connectivity density (/mm³) [20].

2.5. Biomechanical Evaluation

The loading strength of the femoral head was measured using an indentation test with a 2.8-mm-diameter indenter. The proximal femur was fixed and placed on a metal platform of a static materials tester (Z2.5; Zwick / Roell, Ulm, Germany). Alignment of the specimen was adjusted in accordance with the stainless steel rod in the upper holding device. The indenter was displacement-controlled at a constant rate of 5 mm/min and was stopped when the load markedly decreased. The maximum loading strength (N)was automatically record (TestXpert II; Zwick / Roell) [7] (Figure 5).

2.6. RNA Extraction and Quantitative Real-Time

mRNA levels of samples were determined by quantitative real-time PCR. In brief, the RNA of the samples were extracted with Trizol reagents (Invitrogen, USA). The primers (Table 1) were designed by Oligo 6.0 primer design software (Molecular Biology Insights, Colorado Springs, CO, USA) and synthesized by KeDuo (Hangzhou, China). Quantitative real-time PCR reactions were carried out by using a SYBR® Premix Ex Taq™ Kit (TaKaRa Biotech Co, Shiga, Japan). The cycle threshold (Ct) was measured for each mRNA in each sample. The relative quantifications of the gene expressions (BMP-2 and VEGF) were calculated by the formula . ΔΔCt = ΔCt₁-ΔCt₂.ΔCt₁ is the value of the housekeeping gene 18S and ΔCt₂ indicates the Ct value of the target gene [21, 22].

Table 1: Real-time PCR primers and conditions (reproduced from Zhu et al. (2015), under the Creative Commons Attribution License/public domain).

Gene
GeneBank accession
Primer sequences (5’to 3’)
Size (base pairs)
Annealing (°C)

Rabbit BMP-2
NM 001082650
GGGGTGGAACGACTGGATTGTGTCTGCACGATGGCATGGTTAGT
117
64

Rabbit VEGF
AY196796
GGGGGCTGCTGCAATGATGAAAGCTGGCCCTGGTGAGGTTTGAT
97
65

Rabbit 18S
EU236696
GACGGACCAGAGCGAAAGCCGCCAGTCGGCATCGTTTATG
119
64

GeneBank available at http://www.ncbi.nlm.nih.gov/genbank.

2.7. Western Blot Analysis

Protein was isolated with radioimmunoprecipitation assay buffer lysis buffer (Sangon Biotech Co, Ltd). Sodium dodecyl sulfatepolyacrylamide gel (Keduo, Hangzhou, China) was formulated and loaded and electrophoresis occurred prior to transferring to a membrane (Sangon Biotech Co, Ltd), which was closed with skimmed milk powder. The samples were reacted with the primary β-actin antibody, secondary antibody (VEGF and BMP-2, Goat anti-rabbit, Cruz Biotech, Inc, Santa Cruz, CA, USA), and chemiluminescence was performed. The images were analyzed with Bandscan 5.0 (Glyko Inc, Novato, CA, USA) to calculate the intensity of the bands.

2.8. Histologic Evaluation and Immunohistochemistry

Specimens for histological evaluation were fixed in a 4% paraformaldehyde solution. After decalcification in 10% EDTA, the samples were embedded in paraffin. Five-micron sections were cut and stained with hematoxylin and eosin for evaluation of necrosis and calculation of fat cell size. The α-smooth muscle actin staining was used to assess the number and the mean diameter of blood vessels [23].

The slices were examined using a light microscope (Olympus BX51, Tokyo, Japan). Five fields in the subchondral area of the femoral head on each section were chosen [7]. The first field was located at the approximate center of the femoral head and the other four were located on both sides of the first field. The following parameters were assessed: the average diameter of the fat cells [7, 17] and the number and the diameter of blood vessels. Different fields per slice were converted to digital pictures and quantitative analysis was performed using Image-Pro Plus 6.0 (Media Cybernetics Inc, Rockville, MD, USA).

2.9. Statistical Analysis

The data were expressed as the mean ± standard deviation. SPSS 20.0 software (SPSS, Chicago, IL, USA) was used to analyze the data by one-way analysis of variance with Scheffe’s multiple comparison method. p < 0.05 was considered statistically significant.

3. Results

3.1. MRI Two Weeks after Methylprednisolone Injection

The image showed the appearance of the mild edema in the proximal femur (Figure 2).

Figure 2: The edema sign (the yellow arrow) was observed in the proximal femur.

3.2. Mineral Apposition Rate Evaluation

The mineral apposition rate of the femoral head was detected by the distance between the parallel fluorescent bands. The two fluorescent labels (green bands, calcein; red bands, alizarin complexone) were clear (Figure 3). According to the statistical analysis, there was a significant difference in the mineral apposition rate between (2.660 ± 0.2390 μm/d) and (1.913 ± 0.1457 μm/d) (p=0.008; Table 2).

Table 2: Micro-CT, biomechanical and histomorphometric evaluations, and gene expression in the three groups.

BMD (mg/cm²)
883.4 ± 10.28
894.5 ± 12.84
932.6 ± 6.861#

BV/TV (%)
40.30 ± 3.480
41.37 ± 4.612
41.95 ± 7.869

Tb.N (1/mm)
2.079 ±0.08272
2.213 ± 0.07245
2.352 ± 0.06980#

Tb.Th (mm)
0.1705 ± 0.01974
0.1843 ± 0.02414
0.2064 ± 0.01200

Tb.Sp (mm)
0.2672 ± 0.02893
0.2613 ± 0.02759
0.2241 ± 0.009524

Conn.D (1/ mm³)
10.79 ± 1.634
11.29 ± 1.053
14.39 ± 2.148#

Values are mean ± SD.

p < 0.05 vs. .

#p < 0.05 vs. .

BV/TV: bone volume fraction; Tb.N: trabecular number; Tb.Th: trabecular thickness; Tb.Sp: trabecular separation; Conn.D: connective density.

(a)

(b)

(c)

(d)

(e)

(f)

Figure 3: The bone of femoral head was labeled during bone regeneration and remodeling by calcein (green) and alizarin complexone (red). Representative labeling images from each group. The capacity of bone regeneration was the strongest in (f).

(a)

(b)

(c)

(d)

Figure 4: Representative micro-CT images from each group. The trabecular bone In was thicker and denser than that in and that in . (d) Micro-CT-based trabecular architecture and sketches of the region of interest.

(a)

(b)

(c)

Figure 5: (a) Illustrating how the specimen was fixed in dental cement and the force was parallel to the long axis of the proximal femur. (b) Representative load-deformation curve obtained by the biomechanical test. (c) Statistical analyses of the biomechanical test data. p<0.05 vs. the blank group; #p<0.05 vs. .

3.3. Osteogenesis in Femoral Head

Micro-CT images indicated that the trabecular bone was more compact, thicker, and denser in the subchondral bone of (Figure 4) compared with and . The BMD of (932.6 ± 6.861 mg/cm²) was significantly higher than that of (894.5 ± 12.84 mg/cm²) (p < 0.001; Table 2). The trabecular number of (2.352 ± 0.06980 1/mm) was significantly higher than that of (2.213 ± 0.07245 1/mm) (p = 0.039; Table 2).

3.4. Mechanical Strength of Femoral Head

The maximal loading strength of femoral head of (467.2 ± 65.96 N) was significantly greater than that of (365.6 ± 57.40 N, p < 0.001) (Figure 5).

3.5. BMP-2 and VEGF Expression

The mRNA expression of BMP-2, the protein expression of BMP-2, the VEGF mRNA expression, and the VEGF protein expression of were significantly higher than those of (107.7 ± 8.527 vs 39.55 ± 3.141, p < 0.001; 5.753 ± 0.1206 vs 3.860 ± 0.2706, p < 0.001; 16.09 ± 2.911 vs 8.733 ± 0.5577, p=0.006; 5.640 ± 0.2095 vs 3.467 ± 0.1656, p < 0.001; respectively) (Figure 6).

(a)

(b)

Figure 6: (a) These band scans showed the Western blot analysis of BMP-2 and VEGF protein expression in , and . (b) Statistical analyses of the mRNA expressions of BMP-2 and VEGF, protein expression of BMP-2, and VEGF data. p < 0.05 vs. ; #p < 0.05 vs. .

3.6. Histomorphometric Evaluation

The limbs of were observed to have sparse trabeculae (Figure 7(a)) with massive empty lacunae, few osteoblasts, large marrow fat cells, and a disordered architecture of marrow tissue (Figure 7(c)). In contrast, no such changes were observed in (Figures 7(g) and 7(i)). The average fat cell diameter of (28.3 ± 8.4 μm) was lower than that in (34.9 ± 7.5 μm) (p = 0.075, Table 2).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

Figure 7: (a, b) Enlarged and massive fat cells and sparser trabecular bone were shown in . (c) The high-powered field from showed the empty lacunae. There were smaller fat cells, thicker trabecular bone, less bone and marrow necrosis, and less empty osteocyte lacunae in (g, h, and i) compared with that in (a, b, and c) and that in (d, e, and f).

The α-smooth muscle actin staining (Figures 8(a) and 8(b)) showed that the blood vessels in were compressed by enlarged and massive fat cells. The shape of blood vessels seemed normal in . More small blood vessels were observed in compared with and (Figure 8(e)). The number of vessels in (13.7 ± 4.3 /mm²) was significantly higher than that in (4.3 ± 2.2 /mm², p = 0.001; Table 2). The minimal diameter of blood vessels was not statistically different (p = 0.205) between (28.6 ± 4.6 μm) and (23.9 ± 4.2 μm; Table 2).

(a)

(b)

(c)

(d)

(e)

(f)

Figure 8: Examples of a-SMA staining from (a, b) showed that the vessels became flattened, which were compressed by the enlarged fat cells. (e, f) The vessels in seemed normal and more small blood vessels were observed compared with those in (c, d).

4. Discussion

To our knowledge, this is the first study to investigate the bioaccoustic effect of MUS in a rabbit model of steroid-associated osteonecrosis. Our data support the hypothesis that MUS strengthens the repair process of femoral head more efficiently than LIPUS in steroid-associated osteonecrosis. The results provide radiological, biomechanical, molecular biological, and histological evidence to support our speculation that the microbubble use is a promising approach for improving the biological capabilities of LIPUS in bone repair [7].

We found that microbubble enhanced the bioaccoustic effect of LIPUS on bone repair. Our study showed that the loading strength and BMD of the proximal femoral in was statistically higher than that in . This meant that MUS increased the biomechanical strength. Later, histopathology pictures also showed the smaller fat cells, the less bone and marrow necrosis, and the less empty osteocyte lacunae in the compared with . We failed to find the difference of the loading strength and BMD between and . This could be explained by the insonation duration of six weeks, which was a half of the insonation duration in our prior study [7].

The bioeffect of LIPUS, i.e., cavitation, are based on its mechanism of sonoporation [24]. Cavitation-related tissue effects arise from a complex array of interactions between microbubbles and tissue, which include the concomitant process of mechanical effects resulting from microstreaming and microbubble oscillation, growth, and collapse behaviors in the field. Sonoporation may directly increase the protein synthesis, the collagen synthesis, the membrane permeability, the integrin expression, and the cytosolic Ca²⁺ concentration [25]. Previous studies have found that the sonoporation could enhance the osteogenic differentiation and accelerated the osteoblast activity and the bone formation [26]. Our qPCR and Western blot results showed that BMP-2 expression was substantially higher in . It has been established that BMP-2 plays a central role in initiating the bone formation, stimulating the osteogenic differentiation, and increasing the osteoblast activity. The result of the mineral apposition also showed the dramatical new bone formation at the proximal of femoral head in . The data suggested that microbubbles amplified the osteogenetic effect of LIPUS.

Sufficient angiogenesis is a fundamental prerequisite of bone repair. The present study indicated that MUS had great potential in stimulating angiogenesis. Apart from the microbubble-enhanced cavitation, this bioaccoustic effect may account for the promoted production of angiogenic growth factors by MUS. Yoshida et al. [27] found the ultrasonic destruction of microbubbles delivered to the ischemic limbs recruited inflammatory cells producing VEGF. In the present study, we found that the angiogenesis was more vigorous in compared with . Near-normal blood vessels were observed in . The minimal diameter of the blood vessels was also higher in than that in , which could better lead to an increase in blood perfusion.

Microbubbles form endogenously in tissues with the interaction between acoustic pulses and cavitation nuclei [28]. Microbubbles are produced in limited quantities endogenously in tissue. This indicated a need for more ultrasonic energy. However the excessive energy would increase the energy absorption by tissues, resulting in a damage to these tissues. Previous literatures indicated that the cavitation could be amplified by the external microbubbles [14]. In our model, we injected 0.1 ml of microbubble solution intracapsular before insonation and exposed the proximal leg to 200 mW/cm² LIPUS for 20 min per day. Depending on this acoustic pressure, microbubbles presented a stable cavitation, where microbubbles oscillated over many cycles without collapsing. The stable cavitation stimulated by microbubbles was probably responsible for the increased efficiency of LIPUS.

Limitations definitely remained. First, the duration of MUS was set at six weeks. Further studies are required to reveal the saturation point, that is, the length of time after which the bioeffect of MUS is no longer significant. Second, the osteonecrosis lesion hardly led to joint collapse in rabbits. This could be attributed to the dissimilarities in weight bearing between quadrupedal animals and bipedal humans, particularly at the hip [17, 29]. Third, the cellular and the molecular mechanisms of osteogenesis and neovascularization by MUS need further investigation.

5. Conclusions

The present study indicated that MUS outweighed LIPUS on promoting the osteogenesis and the neovascularization in a steroid-associated osteonecrosis model. Without increasing the intensity of insonation and the risk of tissue damage, MUS strengthened the femoral head which might prevent its further collapse. MUS holds more promise in inhibiting the pathological process of steroid-associated osteonecrosis than LIPUS.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

All authors indicate they have no conflicts of interest.

Acknowledgments

The authors are supported by the grant from National Natural Science Foundation of China (81472113). The authors wish to thank Han-Xiao Zhu, Fang-Gang Bi, and Chi-Yuan Ma for their help in the experiment work.

References

D. F. Amanatullah, E. J. Strauss, and P. E. Di Cesare, “Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management,” The American Journal of Orthopedics, vol. 40, no. 9, pp. E186–E192, 2011.

Y. Assouline-Dayan, C. Chang, A. Greenspan, Y. Shoenfeld, and M. E. Gershwin, “Pathogenesis and natural history of osteonecrosis,” Seminars in Arthritis and Rheumatism, vol. 32, no. 2, pp. 94–124, 2002.

K.-H. Koo, R. Kim, Y.-S. Kim et al., “Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment,” Clinical Rheumatology, vol. 21, no. 4, pp. 299–303, 2002.

K. Miyanishi, T. Yamamoto, T. Irisa et al., “Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis,” Bone, vol. 30, no. 1, pp. 185–190, 2002.

G. Motomura, T. Yamamoto, K. Miyanishi, A. Yamashita, K. Sueishi, and Y. Iwamoto, “Bone marrow fat-cell enlargement in early steroid-induced osteonecrosis—a histomorphometric study of autopsy cases,” Pathology - Research and Practice, vol. 200, no. 11-12, pp. 807–811, 2005.

E. Mutijima, V. De Maertelaer, M. Deprez, M. Malaise, and J.-P. Hauzeur, “The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its distribution,” Clinical Rheumatology, vol. 33, no. 12, pp. 1791–1795, 2014.

H. Zhu, X. Cai, T. Lin, Z. Shi, and S. Yan, “Low-intensity pulsed ultrasound enhances bone repair in a rabbit model of steroid-associated osteonecrosis,” Clinical Orthopaedics and Related Research, vol. 473, no. 5, pp. 1830–1839, 2015.

S.-G. Yan, L.-Y. Huang, and X.-Z. Cai, “Low-intensity pulsed ultrasound: A potential non-invasive therapy for femoral head osteonecrosis,” Medical Hypotheses, vol. 76, no. 1, pp. 4–7, 2011.

B. Hu, X.-Z. Cai, Z.-L. Shi et al., “Microbubble injection enhances inhibition of low-intensity pulsed ultrasound on debris-induced periprosthetic osteolysis in rabbit model,” Ultrasound in Medicine & Biology, vol. 41, no. 1, pp. 177–186, 2015.

N. T. Blum, A. Yildirim, R. Chattaraj, and A. P. Goodwin, “Nanoparticles formed by acoustic destruction of microbubbles and their utilization for imaging and effects on therapy by high intensity focused ultrasound,” Theranostics, vol. 7, no. 3, pp. 694–702, 2017.

S. Ibsen, C. E. Schutt, and S. Esener, “Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment,” Drug Design, Development and Therapy, vol. 7, pp. 375–388, 2013.

D. L. Miller, C. Dou, X. Lu et al., “Use of theranostic strategies in myocardial cavitation-enabled therapy,” Ultrasound in Medicine & Biology, vol. 41, no. 7, pp. 1865–1875, 2015.

N. Sakata, N. Sax, G. Yoshimatsu et al., “Enhanced ultrasonography using a nano/microbubble contrast agent for islet transplantation,” American Journal of Transplantation, vol. 15, no. 6, pp. 1531–1542, 2015.

H.-X. Zhu, X.-Z. Cai, Z.-L. Shi, B. Hu, and S.-G. Yan, “Microbubble-mediated ultrasound enhances the lethal effect of gentamicin on planktonic Escherichia coli,” BioMed Research International, vol. 2014, Article ID 142168, 7 pages, 2014.

I. Lentacker, I. De Cock, R. Deckers, S. C. De Smedt, and C. T. W. Moonen, “Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms,” Advanced Drug Delivery Reviews, vol. 72, pp. 49–64, 2014.

J. Ma, C. S. Xu, F. Gao, M. Chen, F. Li, and L. F. Du, “Diagnostic and therapeutic research on ultrasound microbubble/nanobubble contrast agents (Review),” Molecular Medicine Reports, vol. 12, no. 3, pp. 4022–4028, 2015.

L. Qin, G. Zhang, H. Sheng et al., “Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone,” Bone, vol. 39, no. 4, pp. 863–871, 2006.

X. Wu, S. Yang, D. Duan, Y. Zhang, and J. Wang, “Experimental osteonecrosis induced by a combination of low-dose lipopolysaccharide and high-dose methylprednisolone in rabbits,” Joint Bone Spine, vol. 75, no. 5, pp. 573–578, 2008.

S. M. van Gaalen, M. C. Kruyt, R. E. Geuze, J. D. de Bruijn, J. Alblas, and W. J. A. Dhert, “Use of fluorochrome labels in in vivo bone tissue engineering research,” Tissue Engineering Part B: Reviews, vol. 16, no. 2, pp. 209–217, 2010.

M. L. Bouxsein, S. K. Boyd, B. A. Christiansen, R. E. Guldberg, K. J. Jepsen, and R. Müller, “Guidelines for assessment of bone microstructure in rodents using micro-computed tomography,” Journal of Bone and Mineral Research, vol. 25, no. 7, pp. 1468–1486, 2010.

W.-H. Cheung, S. K.-H. Chow, M.-H. Sun, L. Qin, and K.-S. Leung, “Low-intensity pulsed ultrasound accelerated callus formation, angiogenesis and callus remodeling in osteoporotic fracture healing,” Ultrasound in Medicine & Biology, vol. 37, no. 2, pp. 231–238, 2011.

W. Wang, L. Liu, X. Dang, S. Ma, M. Zhang, and K. Wang, “The effect of core decompression on local expression of BMP-2, PPARγ- and bone regeneration in the steroid-induced femoral head osteonecrosis,” BMC Musculoskeletal Disorders, vol. 13, 2012.

S. Barzelai, O. Sharabani-Yosef, R. Holbova et al., “Low-intensity ultrasound induces angiogenesis in rat hind-limb ischemia,” Ultrasound in Medicine & Biology, vol. 32, no. 1, pp. 139–145, 2006.

Y. Khan and C. T. Laurencin, “Fracture repair with ultrasound: Clinical and cell-based evaluation,” The Journal of Bone & Joint Surgery, vol. 90, no. 1, pp. 138–144, 2008.

G. Kasturi and R. A. Adler, “Mechanical means to improve bone strength: Ultrasound and vibration,” Current Rheumatology Reports, vol. 13, no. 3, pp. 251–256, 2011.

X.-H. Xie, X.-L. Wang, G. Zhang et al., “Impaired bone healing in rabbits with steroid-induced osteonecrosis,” The Journal of Bone & Joint Surgery (British Volume), vol. 93, no. 4, pp. 558–565, 2011.

J. Yoshida, K. Ohmori, H. Takeuchi et al., “Treatment of ischemic limbs based on local recruitment of vascular endothelial growth factor-producing inflammatory cells with ultrasonic microbubble destruction,” Journal of the American College of Cardiology, vol. 46, no. 5, pp. 899–905, 2005.

J. E. Parsons, C. A. Cain, G. D. Abrams, and J. B. Fowlkes, “Pulsed cavitational ultrasound therapy for controlled tissue homogenization,” Ultrasound in Medicine & Biology, vol. 32, no. 1, pp. 115–129, 2006.

L.-Z. Zheng, Z. Liu, and M. Lei, “Steroid-associated hip joint collapse in bipedal emus,” PLoS ONE, vol. 8, no. 10, Article ID e76797, 2013.